Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Regenxbio (RGNX) Receivables - Other (2017 - 2025)

Regenxbio has reported Receivables - Other over the past 10 years, most recently at $10.9 million for Q4 2025.

  • Quarterly results put Receivables - Other at $10.9 million for Q4 2025, down 45.79% from a year ago — trailing twelve months through Dec 2025 was $10.9 million (down 45.79% YoY), and the annual figure for FY2025 was $10.9 million, down 45.79%.
  • Receivables - Other for Q4 2025 was $10.9 million at Regenxbio, down from $17.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for RGNX hit a ceiling of $33.5 million in Q2 2022 and a floor of $28000.0 in Q2 2025.
  • Median Receivables - Other over the past 5 years was $8.0 million (2023), compared with a mean of $12.0 million.
  • Peak annual rise in Receivables - Other hit 6463.71% in 2025, while the deepest fall reached 99.71% in 2025.
  • Regenxbio's Receivables - Other stood at $1.1 million in 2021, then surged by 2416.48% to $27.0 million in 2022, then tumbled by 81.5% to $5.0 million in 2023, then soared by 302.12% to $20.1 million in 2024, then tumbled by 45.79% to $10.9 million in 2025.
  • The last three reported values for Receivables - Other were $10.9 million (Q4 2025), $17.0 million (Q3 2025), and $28000.0 (Q2 2025) per Business Quant data.